
CRVS
USDCorvus Pharmaceuticals Inc. Common Stock
$7.600-0.090 (-1.170%)
リアルタイム価格
Healthcare
バイオテクノロジー
米国
価格チャート
Loading Chart...
主要指標
市場指標
始値
$7.690
高値
$7.780
安値
$7.010
出来高
0.51M
企業ファンダメンタルズ
時価総額
567.6M
業種
バイオテクノロジー
国
United States
取引統計
平均出来高
0.85M
取引所
NGM
通貨
USD
52週レンジ
安値 $2.54現在値 $7.600高値 $10
関連ニュース
GlobeNewswire
Corvus Pharmaceuticals to Present Final Data from Soquelitinib Phase 1/1b T Cell Lymphoma Trial at the 67th American Society of Hematology Annual Meeting & Exposition
SOUTH SAN FRANCISCO, Calif., Nov. 03, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that final data from its Phase 1/1b trial of
もっと見る
GlobeNewswire
Corvus Pharmaceuticals to Present at the Guggenheim 2nd Annual Healthcare Innovation Conference
SOUTH SAN FRANCISCO, Calif., Oct. 31, 2025 (GLOBE NEWSWIRE) -- Corvus Pharmaceuticals, Inc. (NASDAQ:CRVS), a clinical-stage biopharmaceutical company, today announced that members of its leadership team will conduct
もっと見る
PR Newswire
The Institute for Follicular Lymphoma Innovation (IFLI) Appoints Innovative Leaders Mehrdad Mobasher, M.D., M.P.H., and Carol O'Hear, M.D., Ph.D., as Executive Partners
The Institute for Follicular Lymphoma Innovation (IFLI), a global, non-profit, private foundation dedicated to accelerating the development of...
もっと見る